The East African Community Competition Authority is considering
approval fees for companies seeking to expand into the region through
mergers and acquisitions.
This would raise the cost of
cross-border investment and put the region at par with other blocs such
as the Common Market for Eastern and Southern Africa, which levy filing
fees on such transactions.
Already, the competition
watchdog is carrying out a study to determine how much firms would be
required to pay, insisting that while filing fees are essential to
facilitate merger and acquisition investigations, they do not want to
discourage investments into the region.
“The authority
is therefore commencing a study to review the merger and acquisition
framework, which among others will inform the Authority on the
notification fees to charge,” said deputy registrar in- charge of
mergers and acquisitions Lilian Mukoronia.
“But the fees should be charged in a way that they don’t discourage investment in the EAC region.”
In
the Comesa, the merger notification fee is calculated as 0.1 per
cent of the merging parties’ combined annual turnover or the value of
assets in the Common Market (whichever is higher) with a cap of
$200,000.
The fee applies to only mergers which affect
at least two of the 19 Comesa markets and for firms with a combined
turnover of $5 million.
The Comesa Competition Commission reportedly earned $3.14 million in merger filing fees between December 2015 and October 2016.
Last
year South African Competition Commission increased the merger filing
fee for large mergers to ZAR 500,000 ($ 40,528) from ZAR 350,000
($28,370) and for medium mergers to ZAR 150,000 ($12,158) from ZAR
100,000 ($8,105).
The proposed introduction of merger
filing fee would enable the regional competition authority to carry out
investigations in cases of over-pricing of a transaction.
The
EAC Competition Act 2006, which came into force in December 2014,
provides for notification of mergers and acquisitions, notification of
subsidies granted by partner states and regulates public procurement.
The
Act prohibits anti-competitive trade practices and abuse of market
dominance and mandates the Authority to promote and protect fair
competition in the Community and to provide for consumer welfare.
The
Authority is also investigating firms and trade associations engaged in
trade malpractices and exploitation of consumers through price fixing.
It is also undertaking sector studies to inform the competitiveness of
the regional economy.
Between January and March this
year the Comesa Competition Commission has handled 12 merger
transactions largely in petroleum, energy, construction, ICT and
Communications, alcoholic and non-alcoholic beverages sectors.
Globally, competition authorities are prioritising excessive pricing cases.
For
instance in December 2016, the UK’s Competition and Markets Authority
imposed a record breaking fine against Pfizer ($117 million) and Flynn
($7 million) for abusing their dominant position by charging excessive
and “unfair” prices for phenytoin sodium, an anti-epilepsy drug.
Excessive pricing cases in the pharmaceutical sector are a current enforcement priority in a number of jurisdictions.
In
Italy, Aspen was fined by the Italy Competition Authority for
excessively pricing a number of cancer drugs and the Competition
Commission of South Africa is investigating Roche and Pfizer for
excessive pricing in relation to a number of products.
No comments:
Post a Comment